YL
Therapeutic Areas
Airiver Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Airiver Pulmonary Drug Coated Balloon | Benign Central Airway Stenosis | Pivotal |
| Airiver Drug Coated Balloon | Chronic Rhinosinusitis (CRS) | Pivotal |
Leadership Team at Airiver Medical
LW
Lixiao Wang
Founder, Chief Executive Officer & Chief Technology Officer
PV
Paul Vajgrt
Chief Operating Officer
JN
James Ness
Chief Financial Officer
ME
Mitch Erickson
Director, R&D
RS
Robyn Schacherer
Director, Clinical Operations
CM
Chad Mellingen
Director, Quality
AW
Amy Wolbeck
Consultant, Regulatory Affairs